Lastly, for clinical applications, it is imperative to recognize that if the elimination of USP7/RBPJ dual-edited cells is compromised, the resultant accumulation of a substantial number of highly proliferative and cytotoxic T cells could significantly elevate the risk of T cell lymphoma and cytokine storm. The gene discussed is RBPJ; the disease is T-cell non-Hodgkin lymphoma.